John Stuelpnagel Insider Profile
25 Followers
John Stuelpnagel, Director at 10x Genomics, holds 328.44K shares in 10x Genomics (Ticker: TXG), holds 337.84K shares in Illumina (Ticker: ILMN). Most recently, John Stuelpnagel Sold ― shares of 10x Genomics on Sep 08, 2026 for an estimated value of $1.23M.
John Stuelpnagel's Trading History
You May Also Like
John Stuelpnagel insider profile FAQ
What is the percentage of profitable transactions made by John Stuelpnagel?
The percentage of profitable transactions made by John Stuelpnagel is 67%.
What is the average return per transaction made by John Stuelpnagel?
The average return per transaction made by John Stuelpnagel is 22.40%.
What stocks does John Stuelpnagel hold?
John Stuelpnagel holds: TXG, ILMN stocks.
What was John Stuelpnagel’s latest transaction?
John Stuelpnagel’s latest transaction was an Informative Sell of $1.23M.
What was John Stuelpnagel's most profitable transaction?
John Stuelpnagel’s most profitable transaction was an Informative Sell of TXG stock on June 7, 2023. The return on the trade was 59.50%.
What is John Stuelpnagel's role in 10x Genomics?
John Stuelpnagel's role in 10x Genomics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.